CompanyInvestor RelationsStem Cell StorageCell ExpansionCell TherapiesResearch and DevelopmentCompany NewsScientific NewsContact
    
 
  • Company
  • Shareholder
  • Share Price
  • Analyst
  • Financial Reporting
  • Accounting policies
  • Calendar
  • Investor News
  • Contact
    		•
    Investor Relations / Shareholder / Shareholders

    Shareholders

     

     

     

    Since Cryo-Save Group N.V. is not incorporated in the UK, the rights of shareholders may be different from the rights of shareholders in a UK incorporated company.


    As at 6 November 2007 the number of securities in issue was 48.176.250, and the percentage of AIM securities not in public hands was 25.83%.

     

     

    Percentage holdings of its significant shareholders

     

     

    • Johan Paul Georges Goossens 13.31%

     

    • Marc Jan Waeterschoot 12.15%

     

    • Pharmaceutical Enterprises S.A. 6.18%

     

    • Fidelity International Limited 4.47%

     

    • Perenco Finvest Limited 3.32%

     

    		  
      europe flag
    Europe's leading family stem cell bank - 4 laboratories - 37 countries -
    3 continents


    Use of this website signifies your agreement to the Disclaimer.
    ©2008 Cryo-Save Group N.V. All rights reserved.